Literature DB >> 30918089

Dimethyl fumarate-induced changes in the MS lymphocyte repertoire: No need for subset monitoring.

Joep Killestein1, Anthony T Reder2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30918089     DOI： 10.1212/WNL.0000000000007255

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  Multiple sclerosis.

Authors:  Shilpa Klocke; Nicole Hahn
Journal:  Ment Health Clin       Date:  2019-11-27

2.  Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial.

Authors:  Helene Højsgaard Chow; Jacob Talbot; Henrik Lundell; Camilla Gøbel Madsen; Lisbet Marstrand; Theis Lange; Mie Reith Mahler; Sophie Buhelt; Rikke Holm Hansen; Morten Blinkenberg; Jeppe Romme Christensen; Per Soelberg Sørensen; Marina Rode von Essen; Hartwig Roman Siebner; Finn Sellebjerg
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-08-24

3.  A retrospective analysis of changes in lymphocyte levels in patients with multiple sclerosis during and after Tecfidera® treatment.

Authors:  Maria-Elizabeth Baeva; Philip Boris Baev; Jill Nelson; Anna Kazimirchik; Galina Vorobeychik
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.